Shopping Cart
- Remove All
- Your shopping cart is currently empty
G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the FLT3 wild type and mutants.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $40 | In Stock | |
5 mg | $64 | In Stock | |
10 mg | $108 | In Stock | |
25 mg | $239 | In Stock | |
50 mg | $396 | In Stock | |
100 mg | $659 | In Stock | |
200 mg | $815 | In Stock | |
500 mg | $1,230 | In Stock |
Description | G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the FLT3 wild type and mutants. |
Targets&IC50 | Mer:1 nM, FLT3 (D835Y):0.6 nM, RET:9 nM, FLT3:0.4 nM, Aurora B:6 nM |
In vitro | In primary cells from AML patients, G-749 was able to inhibit cell proliferation by inducing apoptosis. In BaF3 cell lines stably expressing FLT3-ITD/N676D, FLT3-ITD/F691L, FLT3-D835Y, or FLT3-D835Y/N676D (IC50 <10 nM), G-749 showed significant inhibitory activity. |
In vivo | In primary cells from AML patients, G-749 was able to inhibit cell proliferation by inducing apoptosis. In BaF3 cell lines stably expressing FLT3-ITD/N676D, FLT3-ITD/F691L, FLT3-D835Y, or FLT3-D835Y/N676D (IC50 <10 nM), G-749 showed significant inhibitory activity. |
Kinase Assay | Kinase assay: Activity assays are conducted using Lance Ultra time-resolved fluorescence resonance energy transfer (TR-FRET) technology from Perkin-Elmer. Briefly, 10 ng/mL FLT3 enzyme, a serial diluted G-749, 80 nM substrate of ULight-poly-GT peptide and variable amounts of ATP (8.5 μM to 1088 μM) are mixed in kinase assay buffer (50 mM HEPES pH 7.5, 10 mM MgCl2, 1 mM EGTA, 2 mM DTT and 0.01% Tween-20) and are added to a 384-well OptiPlate-384 in a volume of 10 μL. Kinase reactions are incubated at room temperature for up to 1 h and then stopped by the addition of 5 μL of 10 mM EDTA. A volume of 5 μL of the specific Eu-labeled-anti-phosphopeptide antibody diluted in LANCE Detection Buffer is then added to a final concentration of 2 nM. After 30-minute incubation, assay plates are incubated at 23°C and the LANCE signal is measured on an EnVision Multilabel Reader. Excitation wavelength is set at 320 nm and emission monitored at 615 nm (donor) and 665 nm (acceptor). The IC50 is calculated using nonlinear regression analysis analysis by GradPad Prism 5. |
Cell Research | Cells are seeded at a density of 2 ×104 cells per well and treated with the indicated concentrations of test inhibitor for 72 hours at 37℃. The conditioned medium (CM) is prepared from HS-5 cell culture for 5 days under routine culture conditions, clarified by centrifugation, and used immediately. The CM is added to complete medium at a final concentration of 35%. In coculture experiments, 5 ×104 AML blast cells are plated in 24-well plates containing 1 ×104 HS-5 monolayers and then cultured for at least 48 hours before the exposure of inhibitors. Cell viability is determined by an ATPLite assay. (Only for Reference) |
Alias | G749, Denfivontinib |
Molecular Weight | 521.41 |
Formula | C25H25BrN6O2 |
Cas No. | 1457983-28-6 |
Smiles | CN1CCC(CC1)Nc1nc(Nc2ccc(Oc3ccccc3)cc2)c2c(n1)c(Br)c[nH]c2=O |
Relative Density. | 1.487 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: < 1 mg/mL (insoluble or slightly soluble) DMSO: <1 mg/mL (insoluble or slightly soluble) |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.